Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

ONC Stock Performance and Key Statistics

NASDAQ : ONC

BeOne Medicines

$243.64
2.65+1.10%
Open: 3:28 PM

stock performance chart

ONC Fundamental Analysis

Based on recent data, BeOne Medicines Ltd. (ONC) shows an Average True Range (ATR) of 8.67 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 391.54K, indicating liquidity. These fundamental metrics provide insight into ONC's underlying financial health and market activity.

ATR8.67
Enterprise Value-
Avg Vol (3 Months)391.54K
Avg Vol (10 Days)296.87K

ONC Technical Analysis Indicators

BeOne Medicines Ltd. (ONC) technical indicators as of July 8, 2025: the SMA 20 is -5.77%, SMA 50 at -2.71%, and SMA 200 at 6.27%. The RSI 14 value is 42.8, suggesting its current momentum. These technical analysis signals help assess ONC's price trends and potential future movements.

SMA 20-5.77%
SMA 50-2.71%
SMA 2006.27%
RSI 1442.8

ONC Stock Performance Overview

BeOne Medicines Ltd. (ONC) stock performance overview as of July 8, 2025: The 52-week high is $287.88 (currently -16.29% below), and the 52-week low is $143 (currently 69.71% above). Over the past year, ONC's performance is 66.33%, compared to the S&P 500's 11.81% change.

52-Week High287.88
52-Week High Chg-16.29%
52-Week Low143
52-Week Low Chg+69.71%
S&P 500 52-Week Chg11.81%

BeOne Medicines Ltd. (ONC) Historical Stock Performance

According to market data, BeOne Medicines Ltd. (ONC) stock's recent performance metrics show that over the last month, ONC is -4.26%, with a Year-to-Date (YTD) performance of 30.47%. Over the past year, the stock has seen a 66.33% change. These figures summarize ONC's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High247.52284.51284.51287.88287.88287.88
Low239.25239.25196.53172.67143172.67
Performance-0.09%-4.26%-12.30%+31.11%+66.33%+30.47%

Industry Analysis and Valuation

According to current financial data, ONC stock's P/E (TTM) ratio is -65.78, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ONC, including P/S (5.74), P/B (7.38), and P/FCF (-99.75), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationONCSector MedianIndustry AvgS&P 500
P/E (TTM)-65.78-1.23-6.1832.59
P/S (TTM)5.743.771.615.98
P/B (TTM)7.381.26-7.455.52
P/FCF (TTM)-99.75-1.1111.6724.11

Frequently Asked Questions

How is ONC price-to-earnings ratio currently?
ONC has a current P/E ratio of -65.78
How are ONC's price-to-sale and price-to-book ratios?
The ONC stock has a trailing twelve month price-to sales (P/S) ratio of 5.74 while its price-to-book (P/B) value is 7.38.
Is BeOne Medicines Ltd.'s price-to-cashflow ratio high or low?
ONC's price-to-free-cashflow (P/FCF) ratio is -99.75, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for ONC?
Based on ONC's recent bid, its distance from 20 days simple moving average is -5.77%. It is -2.71% apart from 50 days simple moving average, and it is 6.27% apart from 200 days simple moving average.
What is the 52-week price range for ONC?
The 52-week high for ONC is $287.88 which is -16.29% away from the current price level whereas the distance of that from the 52-week low of $142.00 stands at 69.71%.
An overview of ONC's stock performance: how did it fare?
The performance of ONC stock was not encouraging with most of its significant price indicators in green. BeOne Medicines Ltd.(NASDAQ: ONC) shares have moved downward -1.83% or -$4.50 in the latest trading session and have gained 30.47% year-to-date (YTD). The stock has gained nearly 66.33% over the past year. After moving -12.3% over the trailing 3-month period, the stock is 31.11% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -0.09% a week and -4.26% a month.
What is ONC's 14-day relative strength index (RSI)?
The current 14-day RSI for ONC stock is 42.8. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For ONC, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, BeOne Medicines Ltd. (ONC) has a 14-day ATR of 8.67.
What is ONC's current enterprise value?
After closing at $245.49 with 99.37M of its shares outstanding, the current enterprise value of ONC is roughly -.
Over the past year, how has the stock price of ONC changed?
BeOne Medicines Ltd. (NASDAQ: ONC) is up 66.33% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 11.81%. ONC stock price is also up 30.47% on its value in year-to-date trading.
What is the average trading volume for ONC shares?
The number outstanding shares of ONC is 99.37M, and of these 781.66% shares are freely available for trading. On average, ONC stock has traded 296.87K shares per day for the past 10 days. A total of 320.9K shares changed hands during the last trading session with the average session volume of 410.48K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph